Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016
"Growth
Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor
or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
Global
Markets Directs, Growth Hormone Secretagogue Receptor Type 1 (GH
Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline
Review, H2 2016, provides in depth analysis on Growth Hormone
Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or
Ghrelin Receptor or GHSR) targeted pipeline therapeutics.
The
report provides comprehensive information on the Growth Hormone
Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or
Ghrelin Receptor or GHSR) , targeted therapeutics, complete with
analysis by indications, stage of development, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in Growth Hormone Secretagogue
Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or
GHSR) targeted therapeutics development and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide
Receptor or Ghrelin Receptor or GHSR)
-
The report reviews Growth Hormone Secretagogue Receptor Type 1 (GH
Releasing Peptide Receptor or Ghrelin Receptor or GHSR) targeted
therapeutics under development by companies and universities/research
institutes based on information derived from company and
industry-specific sources
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide
Receptor or Ghrelin Receptor or GHSR)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
Comments
Post a Comment